Rebif (interferon beta-1a) is a disease-modifying therapy for relapsing forms of MS. Learn about its uses, indications, and side effects.| Multiple Sclerosis News Today
Ocrevus (ocrelizumab) is an infusion therapy approved to treat adults with relapsing forms of MS and primary progressive MS.| Multiple Sclerosis News Today
A growing body of evidence has suggested EBV is a major environmental risk factor for MS. Learn more about its association with the disease.| Multiple Sclerosis News Today
MS is categorized into four main types: CIS, RRMS, SPMS, and PPMS. Learn more about each different type, their presentation, and treatment.| Multiple Sclerosis News Today
Symptoms and early signs of MS vary from person to person. Common symptoms include movement problems, pain, fatigue, and vision problems.| Multiple Sclerosis News Today
MS is not usually fatal, but it may increase the risk of life-threatening complications. Learn more about MS progression and life expectancy.| Multiple Sclerosis News Today
Most nonactive SPMS patients who took foralumab nasal spray for at least six months saw a decrease in microglial activity in their brains.| Multiple Sclerosis News Today